Parameter
| Biomarker | CD64 | Full name | Cluster of Differentiation 64 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Disease progression monitoring, pathogenesis-related |
| Disease | Autoimmune Disease (AD) | Disease Subtypes | / | ||
| Organ | Spleen, thymus, lymphoid tissue | Test Sample / Technology Platform | Peripheral blood mononuclear cells (flow cytometry) | ||
| Pathobiological Mechanisms | Increased expression in circulating monocytes, associated with SLEDAI and anti-Sm antibodies, and involved in the regulation of skin inflammation. | ||||
| Clinical Availability Status | Research validation: Observational SLE progression serves as a mechanistic checkpoint in pathogenesis. | ||||
| Notes and Dynamics | Identify potential targets for interventions related to lupus skin inflammation. | ||||